APOGEE THERAPEUTICS, INC. COMMON STOCK
NASDAQ: APGE (Apogee Therapeutics, Inc.)
最近更新时间: 1小时之前134.75
0.00 (0.00%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Apogee Therapeutics, Inc. | 混合的 | 混合的 |
AIStockmoo 评分
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.50 |
|
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 7.62% |
| 机构持股比例 | 137.71% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Venrock Adviser, Llc | 30 Jun 2026 | 8,493,321 |
| Hbk Investments L P | 30 Jun 2026 | 2,850,000 |
| Fmr Llc | 30 Jun 2026 | 2,493,137 |
| Driehaus Capital Management Llc | 30 Jun 2026 | 1,740,101 |
| Balyasny Asset Management L.P. | 30 Jun 2026 | 1,665,102 |
| Glazer Capital, Llc | 30 Jun 2026 | 1,641,042 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合